Nabriva Therapeutics PLC (NASDAQ:NBRV)
| 0.1941 Delayed Data As of Aug 12 |  +0.0006 / +0.31%Today’s Change | 0.16 Today|||52-Week Range 1.40 | -67.59% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 36.4M | 32.8M | 86.8M | 102.0M | |
| Short Term Investment Cash | 35.2M | -3.7M | 54.0M | 15.2M | ||
| Cash & Short Term Investments | 111.2M | 83.9M | 86.9M | 102.2M | ||
| Receivables | Receivables | 4.2M | 5.6M | 5.4M | 5.4M | |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Prepaid Expenses | 608.3K | 1.2M | 1.6M | 1.2M | |
| Current Assets | 116.0M | 90.6M | 93.8M | 108.8M | ||
| Total Assets | Property, Plant and Equipment - Gross | 88.0K | 3.3M | 4.4M | 4.6M | |
| Depreciation | -39.1K | -2.8M | -3.0M | -3.5M | ||
| Intangible Assets | 3.3K | 270.0K | 172.0K | 98.0K | ||
| Other Assets | 3.3K | 270.0K | 172.0K | 98.0K | ||
| Total Assets | 117.6M | 93.2M | 95.8M | 110.4M | ||
| Liabilities | Accounts Payable | -- | 2.6M | 5.1M | 3.3M | |
| Accrued Expenses | 3.3M | 0.00 | -- | -- | ||
| Other Current Liabilities | 7.5M | 11.2M | 3.7M | 7.1M | ||
| Other Liabilities | 9.3M | 15.9M | 13.3M | 17.8M | ||
| Total Liabilities | Long Term Debt | 0.00 | 0.00 | 232.0K | 23.7M | |
| Deferred Taxes | -614.8K | -1.4M | 0.00 | -- | ||
| Other Liabilities | 0.00 | 107.0K | 203.0K | 264.0K | ||
| Total Liabilities | 9.5M | 16.0M | 13.7M | 41.8M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 108.1M | 77.3M | 82.1M | 68.6M | ||
| Total Shareholder Equity | 108.1M | 77.3M | 82.1M | 68.6M | ||
| Share Information | Common Shares Outstanding | 2.1M | 2.7M | 36.7M | 67.0M | |
| Addtl. Info. | No data currently available for this section. | |||||
